Epidemiology of mycobacterium bovis disease in humans, The Netherlands, 1993-2007

Emerging Infectious Diseases

Volumn 17, Issue 3, 2011, Pages 457-463

  Majoor, Christof J ^a   Magis Escurra, Cecile ^b   van Ingen, Jakko ^b,c   Boeree, Martin J ^b   van Soolingen, Dick ^b,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; MOXIFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BOVINE TUBERCULOSIS; CAUSE OF DEATH; CHILD; COUGHING; DISEASE TRANSMISSION; DNA FINGERPRINTING; DYSPNEA; ETHNICITY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN TISSUE; INFANT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MORTALITY; MULTIPLE PULMONARY NODULES; MYCOBACTERIUM BOVIS; NETHERLANDS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; SCHOOL CHILD; SKIN BIOPSY; TREATMENT OUTCOME; TUBERCULOUS LYMPHADENITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DNA FINGERPRINTING; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYCOBACTERIUM BOVIS; NETHERLANDS; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS, LYMPH NODE; TUBERCULOSIS, PULMONARY;

EID: 79952346605     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1703.101111     Document Type: Article

References (31)

1. Ruys AC. Tuberculosis caused by M. bovis in humans in the Netherlands [in Dutch]. Ned Tijdschr Geneeskd. 1938;83:1001-7.
2. Ruys AC. The treatment of bovine tuberculosis and epidemiological changes in tuberculosis [in Dutch]. Ned Tijdschr Geneeskd. 1952;96:676-81.
3. Schönfeld JK. Infection caused by bovine tuberculum bacteria in humans in the Netherlands during the period 1972-1975 [in Dutch]. Ned Tijdschr Geneeskd. 1978;122:217-9.
4. Sherman LF, Fujiwara PI, Cook SV, Bazerman LB, Frieden TR. Patient and health care system delays in the diagnosis and treatment of tuberculosis. Int J Tuberc Lung Dis. 1999;3:1088-95.
5. Diwakar L, Logan S, Ghaffar N, Hare A, Lynn W, Ash S. Low back pain: think of tuberculosis. BMJ. 2006;333:201. DOI: 10.1136/bmj.333.7560.201
6. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907-14.
7. Niemann S, Richter E, Rüsch-Gerdes S. Biochemical and genetic evidence for the transfer of Mycobacterium tuberculosis subsp. Caprae Aranaz et al. 1999 to the species Mycobacterium bovis Karlson and Lessel 1970 (approved lists 1980) as Mycobacterium bovis subsp. caprae comb. nov. Int J Syst Evol Microbiol. 2002;52:433-6.
8. Erkens CGM, Kalisvaart NA, Slump E, Sebek M, van Soolingen D. Tuberculosis in the Netherlands 2007. Surveillance report [in Dutch]. KNCV Tuberculosefonds, Den Haag; Jan 2009. http://www.kncvtbc.nl/Site/Professional.aspx
9. Mignard S, Pichat C, Carret G. Mycobacterium bovis infection, Lyon, France. Emerg Infect Dis. 2006;12:1431-3.
10. de la Rua-Domenech R. Human Mycobacterium bovis infection in the United Kingdom: incidence, risks, control measures and review of the zoonotic aspects of bovine tuberculosis. Tuberculosis (Edinb). 2006;86:77-109. DOI: 10.1016/j.tube.2005.05.002
11. Hlavsa MC, Moonan PK, Cowan LS, Navin TR, Kammerer JS, Morlock GP, et al. Human tuberculosis due to Mycobacterium bovis in the United States, 1995-2005. Clin Infect Dis. 2008;47:168-75. DOI: 10.1086/589240
12. Harris NB, Payeur J, Bravo D, Osorio R, Stuber T, Farrell D, et al. Recovery of Mycobacterium bovis from soft fresh cheese originating in Mexico. Appl Environ Microbiol. 2007;73:1025-8. DOI: 10.1128/AEM.01956-06
13. Kinde H, Mikolon A, Rodriguez-Lainz A, Adams C, Walker RL, Cernek-Hoskins S, et al. Recovery of Salmonella, Listeria monocytogenes, and Mycobacterium bovis from cheese entering the United States through a noncommercial land port of entry. J Food Prot. 2007;70:47-52.
14. van Soolingen D, de Haas PE, Haagsma J, Eger T, Hermans PW, Ritacco V, et al. Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosis. J Clin Microbiol. 1994;32:2425-33.
15. van Ingen J, Boeree MJ, Dekhuijzen PNR, van Soolingen D. Mycobacterial disease in patients with rheumatic disease. Nat Clin Pract Rheumatol. 2008;4:649-56. DOI: 10.1038/ncprheum0949
16. Endean L, Barry SM, Young-Min SA. Possible miliary tuberculosis during adalimumab therapy with negative γ-IFN release assays. Rheumatology. 2009;48:319-20. DOI: 10.1093/rheumatology/ken469
17. Yoo WH. Multiple organ tuberculosis of lung, pleura, and peritoneum in ankylosing spondylitis during adalimumab therapy. Rheumatol Int. 2010 Jan 5 [Epub ahead of print]. http://www.springerlink.com/content/0172-812/31/1/
18. Statline. Centraal Bureau voor de Statistiek 2010 [cited 2010 Apr 3]. http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=37296ned&D1=a&D2=0,10,20,30,40,50,(l-1)-l&HD=100105-1504&HDR=G1&STB=T
19. Benkerroum N, Oubel H, Zahar M, Dlia S, Filali-Maltouf A. Isolation of a bacteriocin-producing Lactococcus lactis subsp. lactis and application to control Listeria monocytogenes in Moroccan jben. J Appl Microbiol. 2000;89:960-8. DOI: 10.1046/j.1365-2672.2000.01199.x
20. Aygun O, Pehlivanlar S. Liste ria spp. in the raw milk and dairy products in Antakya, Turkey. Food Control. 17: 676-9.
21. Centers for Disease Control and Prevention. Human tuberculosis caused by Mycobacterium bovis-New York City, 2001-2004. MMWR Morb Mortal Wkly Rep. 2005;54:605-8.
22. van der Merwe M, Bekker JL, van der Merwe P, Michel AL. Cooking and drying as effective mechanisms in limiting the zoonotic effect of Mycobacterium bovis in beef. J S Afr Vet Assoc. 2009;80:142-5.
23. Thoen C, Lobue P, de Kantor I. The importance of Mycobacterium bovis as a zoonosis. Vet Microbiol. 2006;112:339-45. DOI: 10.1016/j.vetmic.2005.11.047
24. Martinez AN, Rhee JT, Small PM, Behr MA. Sex differences in the epidemiology of tuberculosis in San Francisco. Int J Tuberc Lung Dis. 2000;4:26-31.
25. Lin JN, Lai CH, Chen YH, Lee SS, Tsai SS, Huang CK, et al. Risk factors for extra-pulmonary compared to pulmonary tuberculosis. Int J Tuberc Lung Dis. 2009;13:620-5.
26. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis. 2009;49:1350-7. DOI: 10.1086/605559
27. Temple SE, Pham K, Glendenning P, Phillips M, Waterer GW. Endotoxin induced TNF and IL-10 mRNA production is higher in male than female donors: correlation with elevated expression of TLR4. Cell Immunol. 2008;251:69-71. DOI: 10.1016/j.cellimm. 2008.04.013
28. van Eijk LT, Dorresteijn MJ, Smits P, van der Hoeven JG, Netea MG, Pickkers P. Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med. 2007;35:1464-9. DOI: 10.1097/01. CCM.0000266534.14262.E8
29. Rodwell TC, Moore M, Moser KS, Brodine SK, Strathdee SA. Tuberculosis from Mycobacterium bovis in binational communities, United States. Emerg Infect Dis. 2006;14:909-16. DOI: 10.3201/ eid1406.071485
30. Ditah IC, Reacher M, Palmer C, Watson JM, Innes J, Kruijshaar ME, et al. Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective. Thorax. 2008;63:440-6. DOI: 10.1136/thx.2006.073916
31. Fok A, Numata Y, Schulzer M, FitzGerald MJ. Risk factors for clustering of tuberculosis cases: a systematic review of populationbased molecular epidemiology studies. Int J Tuberc Lung Dis. 2008;12:480-92.